Meanwhile, the results of animal experiments also showed that the efficacy and prognosis of immunotherapy had a correlation with the expression of PD-1/PD-L1 on relevant CD8+ T cells in prostate cancer. This evidence concerns the gene CD8A and Familial prostate cancer.